| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.042 | 0.4 |